Type 1 diabetes

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes

DiabetologiaPublished Cross-sectional study

Authors' conclusion

We report the most extensive analysis to date of VP1 and HLA-I in pancreases from donors with preclinical and diagnosed type 1 diabetes. We find an association of VP1 with residual beta cells after diagnosis and demonstrate VP1 positivity during the autoantibody-positive preclinical stage. For the first time, we show that VP1 positivity and HLA-I hyperexpression in islet cells are both present during the preclinical stage. While the study of tissues does not allow us to demonstrate causality, our data support the hypothesis that enterovirus infections may occur throughout the natural history of type 1 diabetes and may be one of multiple mechanisms driving islet cell HLA-I hyperexpression.

Study context

Population
Organ donors (nPOD), including donors with T1D and donors expressing autoantibody risk markers; pancreas, spleen, duodenum and pancreatic lymph nodes
Participants
188 organ donors
Exposure
VP1 positivity and HLA-I hyperexpression in islet cells across donor groups (ND, AAb+, AAb++, T1D-ICIs, T1D-IDIs)
  • NDn = 76reference
  • AAb+n = 20
  • AAb++n = 9
  • T1D-ICIsn = 41
  • T1D-IDIsn = 42
Outcome
Islet cell VP1 positivity (IHC) and its link to HLA-I hyperexpression
Methodological detailsorgan donor tissues (nPOD), two independent laboratories, VP1 by immunohistochemistry (IHC); HLA-I by IHC and immunofluorescence, in two independent laboratories
  • Organ donor tissues (nPOD)
  • Two independent laboratories
  • VP1 by IHC; HLA-I by IHC and immunofluorescence, in two independent laboratories

Main finding

As reported in the abstract

Islet cell VP1 positivity

P < 0.001

Observational data: associations, not effects.

Further findings

HLA-I hyperexpression, all donor groups combined

P < 0.001

Both VP1 immunopositivity and HLA-I hyperexpression, among donors assessed for both

Donors with both VP1 positivity and HLA-I hyperexpression (p<0.001 vs ND)
73.7%

VP1+ cell frequency by HLA-I status

VP1+ cells detected at higher frequency in donors with HLA-I hyperexpression (p<0.001 vs normal HLA-I)

HLA-I hyperexpression among VP1+ donors, AAb++ and T1D-ICIs

Proportion with HLA-I hyperexpression in AAb++ and T1D-ICI groups (p<0.001 vs ND); not restricted to recent-onset diabetes
94.9%

Original publication

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes. Diabetologia. Published 17 March 2025. doi:10.1007/s00125-025-06384-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.